MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The longevity gene Klotho and its CSF protein profiles as modifier for Parkinson´s disease in a longitudinal study

    M. Zimmermann, S. Lerche, C. Schulte, I. Wurster, G. Machetanz, C. Deuschle, A. Hauser, T. Gasser, D. Berg, E. Schleicher, W. Maetzler, K. Brockmann (Tuebingen, Germany)

    Objective: Our objective was to evaluate phenotype modifying effects of variants in longevity genes in PD. Background: Parkinson´s disease (PD) has a large phenotypic variability,…
  • 2019 International Congress

    Temporal Emergence of Symptoms and Functional Impairments in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

    F. Greblikas, HA. Jinnah, T. Klopstock, A. Videnovic, C. Burns (San Diego, CA, USA)

    Objective: To describe the temporal emergence of PKAN symptoms and functional impairments across the spectrum of PKAN severity. Background: PKAN, an autosomal recessive, progressive neurodegenerative…
  • 2019 International Congress

    Case report: Chorea-acynthocytosis with two compoud heterozygous VPS13A large deletions

    D. Spieler, A. Mühlbäck, A. Velayos-Baeza, F. Castrop, C. Maegerlein, J. Slotta-Hispenina, B. Bader, B. Haslinger, J. Klempir, A. Danek (Freiburg, Germany)

    Objective: We report a 33 year old male patient without functional protein due to compound heterozygosity for VPS13A deletions and discuss the molecular diagnostic difficulties…
  • 2019 International Congress

    The effect of ATP13A2/PARK9 levels on a-syn spreading in mice brains

    T. Tsunemi, Y. Ishiguro, A. Okuzumi, A. Yoroisaka, N. Nukina, N. Hattori (Tokyo, Japan)

    Objective: The purpose of this study is to analyze the effect of ATP13A2/PARK9-mediated a-syn secretion on a-syn spreading in mice. Background: Recent studies with cell…
  • 2019 International Congress

    Longitudinal analysis of the modified Hoehn and Yahr disease stage in PD-1101, a Phase 1b clinical study of VY-AADC01

    A. van Laar, R. Richardson, A. Sedkov, E. Fine, K. Bankiewicz, B. Ravina, P. Larson, C. Christine (Pittsburgh, PA, USA)

    Objective: To describe changes over the first year in disease severity and activities of daily living using modified Hoehn and Yahr (mH&Y) stage and UPDRS…
  • 2019 International Congress

    Social Network for the diagnosis of RLS

    C. Guerra-Galicia, J. Blanco-Galina (San Luis Potosí, Mexico)

    Objective: Identify patients with RLS using social media, describe time of evolution, previous diagnosis, treatment, symptoms severity and quality of life perception. Background: RLS is a…
  • 2019 International Congress

    Pilot Study Comparing Home Sleep Profiler to In-laboratory Polysomnogram for REM Sleep Behavior Disorder Diagnosis

    D. Shprecher, D. Levendowski, C. Guevarra, J. Lee-Iannotti, G. Lazarz (Sun City, AZ, USA)

    Objective: To compare the Sleep Profiler (SP), an FDA-approved device for home evaluation of sleep disorders, to the gold standard sleep laboratory polysomnogram (PSG) in…
  • 2019 International Congress

    “So much easier”; patient’s perceptions of Virtual Clinics for Parkinson’s Disease

    L. Evans, B. Mohamed, EC. Thomas (Cardiff, United Kingdom)

    Objective: Our virtual clinic for People with Parkinson’s disease (PwP) is a service innovation, providing a consultation with a Parkinson’s clinic doctor via telephone, with…
  • 2019 International Congress

    Motor and non-motor symptoms burden, autonomy, quality of life and principal caregiver status is worse in patients with 5-2-1 positive criteria: a simple screening tool for identifying PD patients who need an optimization of Parkinson´s treatment.

    D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros (A Coruña, Spain)

    Objective: To compare quality of life (QoL), non-motor symptoms (NMS) burden, autonomy for activities of daily living (ADL) and patient´s principal caregiver status in PD…
  • 2019 International Congress

    Relationship between Progressive Supranuclear Palsy and Caregiver Burden

    Y. Inuzuka, J. de Courcy, J. Pike, J. Mellor, E. Viscidi, A. Paradis, A. Harrington, Y. Zabar (Zug, Switzerland)

    Objective: To understand the relationship between progressive supranuclear palsy (PSP) disease progression and caregiver requirement and burden. Background: PSP is a rare neurodegenerative disease, and…
  • « Previous Page
  • 1
  • …
  • 213
  • 214
  • 215
  • 216
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley